These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 11703886)

  • 1. Treating premenstrual dysphoric disorder using serotonin agents.
    Lin J; Thompson DS
    J Womens Health Gend Based Med; 2001 Oct; 10(8):745-50. PubMed ID: 11703886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Premenstrual dysphoric disorder (PMDD): Drug and psychotherapeutique management, a literature review].
    Marais-Thomas H; Chapelle F; de Vaux-Boitouzet V; Bouvet C
    Encephale; 2024 Apr; 50(2):211-232. PubMed ID: 37821319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Premenstrual dysphoria and the serotonin system: pathophysiology and treatment.
    Steiner M; Pearlstein T
    J Clin Psychiatry; 2000; 61 Suppl 12():17-21. PubMed ID: 11041380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Premenstrual syndrome in adolescents: diagnosis and treatment.
    Rapkin AJ; Mikacich JA
    Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():132-7. PubMed ID: 16641847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation and management of premenstrual syndrome and premenstrual dysphoric disorder.
    Frackiewicz EJ; Shiovitz TM
    J Am Pharm Assoc (Wash); 2001; 41(3):437-47. PubMed ID: 11372908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sertraline in the treatment of premenstrual dysphoric disorder].
    Culav-Sumić J; Skocilić Z; Jukić V
    Lijec Vjesn; 1999; 121(7-8):234-8. PubMed ID: 10573958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective serotonin reuptake inhibitors for premenstrual syndrome.
    Brown J; O' Brien PM; Marjoribanks J; Wyatt K
    Cochrane Database Syst Rev; 2009 Apr; (2):CD001396. PubMed ID: 19370564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing PMS & PMDD. Exploring new treatment options.
    Pritham UA
    AWHONN Lifelines; 2002; 6(5):430-7. PubMed ID: 12420386
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacotherapy of premenstrual syndromes and premenstrual dysphoric disorder: current practices.
    Mitwally MF; Kahn LS; Halbreich U
    Expert Opin Pharmacother; 2002 Nov; 3(11):1577-90. PubMed ID: 12437492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management strategies for premenstrual syndrome/premenstrual dysphoric disorder.
    Jarvis CI; Lynch AM; Morin AK
    Ann Pharmacother; 2008 Jul; 42(7):967-78. PubMed ID: 18559957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of fluoxetine in the treatment of premenstrual dysphoric disorder.
    Romano S; Judge R; Dillon J; Shuler C; Sundell K
    Clin Ther; 1999 Apr; 21(4):615-33; discussion 613. PubMed ID: 10363729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of central serotonergic dysfunction in the aetiology of premenstrual dysphoric disorder: therapeutic implications.
    Parry BL
    CNS Drugs; 2001; 15(4):277-85. PubMed ID: 11463133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis.
    Shah NR; Jones JB; Aperi J; Shemtov R; Karne A; Borenstein J
    Obstet Gynecol; 2008 May; 111(5):1175-82. PubMed ID: 18448752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SSRIs for premenstrual dysphoric disorder.
    Drug Ther Bull; 2002 Sep; 40(9):70-2. PubMed ID: 12298224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective serotonin reuptake inhibitors and treatment of premenstrual dysphoric disorder.
    Finfgeld DL
    Perspect Psychiatr Care; 2002; 38(2):50-60. PubMed ID: 12132631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Premenstrual syndrome.
    Yonkers KA; O'Brien PM; Eriksson E
    Lancet; 2008 Apr; 371(9619):1200-10. PubMed ID: 18395582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The multifactorial aetiology and management of premenstrual dysphoric disorder with leuprorelin acetate.
    Dunphy L; Boyle S; Wood F
    BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38160030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Psychiatric and psychological aspects of premenstrual syndrome].
    Limosin F; Ades J
    Encephale; 2001; 27(6):501-8. PubMed ID: 11865558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of metergoline on symptoms in women with premenstrual dysphoric disorder.
    Roca CA; Schmidt PJ; Smith MJ; Danaceau MA; Murphy DL; Rubinow DR
    Am J Psychiatry; 2002 Nov; 159(11):1876-81. PubMed ID: 12411222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Premenstrual dysphoric disorder: long-term treatment with fluoxetine and discontinuation].
    de la Gándara Martín JJ
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1997; 25(4):235-42. PubMed ID: 9412162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.